{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:49:47Z","timestamp":1759340987779},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.jns.2004.02.020","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T12:31:00Z","timestamp":1083155460000},"page":"99-104","source":"Crossref","is-referenced-by-count":21,"title":["IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy"],"prefix":"10.1016","volume":"221","author":[{"given":"M.M","family":"Mehndiratta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tatke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.K","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2004.02.020_BIB1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal proteins in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2004.02.020_BIB2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0404.1992.tb06033.x","article-title":"Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenic studies","volume":"85","author":"Nobile-Orazio","year":"1992","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2004.02.020_BIB3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/jcp.33.7.617","article-title":"Paraproteinaemia in neurologic diseases; Incidence, associations and classification of monoclonal immunoglobulins","volume":"33","author":"Kahn","year":"1980","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jns.2004.02.020_BIB4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/brain\/117.6.1385","article-title":"Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities","volume":"117","author":"Notermans","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.jns.2004.02.020_BIB5","first-page":"371","article-title":"Polyneuropathy associated with IgA monoclonal gammopathy: a hypothesis of its pathogenesis","volume":"81","author":"Nemni","year":"1991","journal-title":"Acta Neurol. Pathol."},{"key":"10.1016\/j.jns.2004.02.020_BIB6","series-title":"Polyneuropathies associated with plasma cell dyscrasia","first-page":"1","article-title":"Plasma cell dyscrasia: definition and diagnostic evaluation","author":"Kyle","year":"1987"},{"key":"10.1016\/j.jns.2004.02.020_BIB7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0025-6196(12)60015-9","article-title":"\u201cBenign\u201d monoclonal gammopathy\u2014after 20 to 35 years of follow up","volume":"68","author":"Kyle","year":"1993","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jns.2004.02.020_BIB8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jnnp.63.2.163","article-title":"Axonal neuropathy associated with monoclonal gammopathy of undetermined significance","volume":"63","author":"Gorson","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2004.02.020_BIB9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1600-0404.1998.tb00636.x","article-title":"Comparison of IgM-MGUS and IgG-MGUS polyneuropathy","volume":"97","author":"Simoric","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2004.02.020_BIB10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.02.020_BIB11","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.jns.2004.02.020_BIB12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1531-8249(200006)47:6<808::AID-ANA15>3.0.CO;2-8","article-title":"Myelin widening and MGUS-IgA: an immunoelectron microscopic study","volume":"47","author":"Vallat","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.02.020_BIB13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00005072-198207000-00007","article-title":"Peripheral Neuropathy associated with monoclonal gammopathy: studies of intraneural injections of monoclonal immunoglobulin sera","volume":"41","author":"Bosch","year":"1982","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2004.02.020_BIB14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1750-3639.2001.tb00407.x","article-title":"Paraproteinemic neuropathies","volume":"11","author":"Vital","year":"2001","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.jns.2004.02.020_BIB15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11940-001-0050-5","article-title":"Paraproteinemic neuropathy","volume":"3","author":"Wicklund","year":"2001","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jns.2004.02.020_BIB16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<150::AID-MUS2>3.0.CO;2-G","article-title":"Prognosis of neuropathy with monoclonal gammopathy (editorial)","volume":"23","author":"Latov","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2004.02.020_BIB17","doi-asserted-by":"crossref","first-page":":310","DOI":"10.1136\/jnnp.62.4.310","article-title":"Epidemiology of peripheral neuropathy","volume":"62","author":"Maryn","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2004.02.020_BIB18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<164::AID-MUS4>3.0.CO;2-Y","article-title":"Long-term clinical and neurophysiological follow-up of patients with peripheral neuropathy associated with benign monoclonal gammopathy","volume":"23","author":"Ponsford","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2004.02.020_BIB19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mus.880160113","article-title":"Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance","volume":"16","author":"Simmons","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2004.02.020_BIB20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2004.02.020_BIB21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/pgmj.65.767.662","article-title":"Proximal motor neuropathy, IgA paraproteinemia and antimyelin associated glycoprotein reactivity","volume":"65","author":"Hemachudha","year":"1989","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jns.2004.02.020_BIB22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1600-0404.1986.tb04602.x","article-title":"Benign monoclonal IgA kappa gammopathy associated with polyneuropathy and dysautonomia","volume":"73","author":"Baily","year":"1986","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2004.02.020_BIB23","first-page":"979","article-title":"Neuropathies associated with IgG and IgA monoclonal gammopathy","volume":"158","author":"Nobile Orazio","year":"2002","journal-title":"Rev. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X04000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T04:54:31Z","timestamp":1549774471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X04000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0022510X04000644"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2004.02.020","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}